Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile.

Dubbelboer, Ilse R; Pavlovic, Natasa; Heindryckx, Femke; Sjögren, Erik; Lennernäs, Hans

Dubbelboer, Ilse R; Pavlovic, Natasa; Heindryckx, Femke; Sjögren, Erik; Lennernäs, Hans.

Afiliación

Dubbelboer IR; Department of Pharmacy, Uppsala University, Box 580, 751 23 Uppsala, Sweden.
Pavlovic N; Department of Medical Cell Biology, Uppsala University, Box 571, 751 23 Uppsala, Sweden.
Heindryckx F; Department of Medical Cell Biology, Uppsala University, Box 571, 751 23 Uppsala, Sweden.
Sjögren E; Department of Pharmacy, Uppsala University, Box 580, 751 23 Uppsala, Sweden.
Lennernäs H; Department of Pharmacy, Uppsala University, Box 580, 751 23 Uppsala, Sweden. hans.lennernas@farmaci.uu.se.

Cancers (Basel) ; 11(7)2019 Jul 20.

Article en En | MEDLINE | ID: mdl-31330834

Palabras clave

IC50; cell lines; doxorubicin; hypoxia; liver cancer; normoxia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google